Drugs acting on homeostasis: challenging cancer cell adaptation - PubMed (original) (raw)
Review
Drugs acting on homeostasis: challenging cancer cell adaptation
Maria Moschovi et al. Expert Rev Anticancer Ther. 2015.
Abstract
Cancer treatment aims to exploit properties that define malignant cells. In recent years, it has become apparent that malignant cells often survive cancer treatment and ensuing cell stress by switching on auxiliary turnover pathways, changing cellular metabolism and, concomitantly, the gene expression profile. The changed profile impacts the material exchange of cancer cells with affected tissues. Herein, we show that pathways of proteostasis and energy generation regulate common transcription factors. Namely, when one pathway of intracellular turnover is blocked, it triggers alternative turnover mechanisms, which induce transcription factor proteins that control expression of cytokines and regulators of apoptosis, cell division, differentiation, metabolism, and response to hormones. We focus on several alternative turnover mechanisms that can be blocked by drugs already used in clinical practice for the treatment of other non-cancer related diseases. We also discuss paradigms on the challenges posed by cancer cell adaptation mechanisms.
Keywords: cell stress; gene promoter; homeostasis; immune system; metabolism; signal transduction.
Similar articles
- Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L, Fratta E, Coral S, Cortini E, Covre A, Nicolay HJ, Anzalone L, Pezzani L, Di Giacomo AM, Fonsatti E, Colizzi F, Altomonte M, Calabrò L, Maio M. Sigalotti L, et al. J Cell Physiol. 2007 Aug;212(2):330-44. doi: 10.1002/jcp.21066. J Cell Physiol. 2007. PMID: 17458893 Review. - Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators.
Theocharis S, Margeli A, Vielh P, Kouraklis G. Theocharis S, et al. Cancer Treat Rev. 2004 Oct;30(6):545-54. doi: 10.1016/j.ctrv.2004.04.004. Cancer Treat Rev. 2004. PMID: 15325034 Review. - Autism's cancer connection: the anti-proliferation hypothesis and why it may matter.
Ward CS. Ward CS. Med Hypotheses. 2014 Jan;82(1):26-35. doi: 10.1016/j.mehy.2013.10.029. Epub 2013 Nov 11. Med Hypotheses. 2014. PMID: 24275522 - New molecular mechanisms of action of camptothecin-type drugs.
Legarza K, Yang LX. Legarza K, et al. Anticancer Res. 2006 Sep-Oct;26(5A):3301-5. Anticancer Res. 2006. PMID: 17094444 Review. - HSF1-mediated regulation of tumor cell apoptosis: a novel target for cancer therapeutics.
Kumar S, Tomar MS, Acharya A. Kumar S, et al. Future Oncol. 2013 Oct;9(10):1573-86. doi: 10.2217/fon.13.106. Future Oncol. 2013. PMID: 24106905 Review.
Cited by
- Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode.
Vlahopoulos SA. Vlahopoulos SA. Cancer Biol Med. 2017 Aug;14(3):254-270. doi: 10.20892/j.issn.2095-3941.2017.0029. Cancer Biol Med. 2017. PMID: 28884042 Free PMC article. - The Autophagy-Lysosomal Pathways and Their Emerging Roles in Modulating Proteostasis in Tumors.
Dong Z, Cui H. Dong Z, et al. Cells. 2018 Dec 20;8(1):4. doi: 10.3390/cells8010004. Cells. 2018. PMID: 30577555 Free PMC article. Review. - Dissecting pharmacological effects of chloroquine in cancer treatment: interference with inflammatory signaling pathways.
Varisli L, Cen O, Vlahopoulos S. Varisli L, et al. Immunology. 2020 Mar;159(3):257-278. doi: 10.1111/imm.13160. Epub 2019 Dec 22. Immunology. 2020. PMID: 31782148 Free PMC article. Review. - Danshen extract circumvents drug resistance and represses cell growth in human oral cancer cells.
Yang CY, Hsieh CC, Lin CK, Lin CS, Peng B, Lin GJ, Sytwu HK, Chang WL, Chen YW. Yang CY, et al. BMC Complement Altern Med. 2017 Dec 29;17(1):555. doi: 10.1186/s12906-017-2063-y. BMC Complement Altern Med. 2017. PMID: 29284481 Free PMC article. - OGG1 as an Epigenetic Reader Affects NFκB: What This Means for Cancer.
Vlahopoulos S, Pan L, Varisli L, Dancik GM, Karantanos T, Boldogh I. Vlahopoulos S, et al. Cancers (Basel). 2023 Dec 28;16(1):148. doi: 10.3390/cancers16010148. Cancers (Basel). 2023. PMID: 38201575 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources